Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Health Care Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
American Health Care Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2017 · fourth_quarter · Q4
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Source: Senate LDA
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
American Health Care Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
American Health Care Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
FAST Generics Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Lower Drug Costs through Competition Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Affordable and Safe Prescription Drug Importation Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Affordable and Safe Prescription Drug Importation Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Affordable and Safe Prescription Drug Importation Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Affordable and Safe Prescription Drug Importation Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Improving Access To Affordable Prescription Drugs Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2016 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Drug pricing proposals and issues.
PATIENT Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Combination Drug Development Incentive Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Combination Drug Development Incentive Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Combination Drug Development Incentive Act of 2015
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Drug pricing proposals and issues.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Drug pricing proposals and issues.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2016 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Safeguarding America's Pharmaceuticals Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Safeguarding America's Pharmaceuticals Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
Safeguarding America's Pharmaceuticals Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
Safeguarding America's Pharmaceuticals Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Combination Drug Development Incentive Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Combination Drug Development Incentive Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Helping Families in Mental Health Crisis Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
Helping Families in Mental Health Crisis Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Pharmaceutical Quality, Security, and Accountability Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Pharmaceutical Quality, Security, and Accountability Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Pharmaceutical Quality, Security, and Accountability Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
Pharmaceutical Quality, Security, and Accountability Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
Safeguarding America's Pharmaceuticals Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Stop Tampering of Prescription Pills Act of 2013
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Preserve Access to Affordable Generics Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Pharmaceutical Quality, Security, and Accountability Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Pharmaceutical Quality, Security, and Accountability Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Pharmaceutical Quality, Security, and Accountability Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Generic Drug Application Review Fairness Act of 2012
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Funding for FDA offices; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform law; implementation of biologics provisions of healthcare reform law; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act; FDA Innovation & Safety Act; and S.2295, Patient Safety & Generic Labeling Improvement Act.
Generic Drug Application Review Fairness Act of 2012
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Funding for FDA Office of Generic Drugs; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform law; implementation of biologics provisions of healthcare reform law; H.R.5, Help Efficient Accessible Low-Cost Timely Healthcare (HEALTH) Act of 2011; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act
Generic Drug Application Review Fairness Act of 2012
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Funding for FDA offices; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform law; implementation of biologics provisions of healthcare reform law; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act; FDA Innovation & Safety Act; and S.2295, Patient Safety & Generic Labeling Improvement Act.
Generic Drug Application Review Fairness Act of 2012
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
Funding for FDA offices; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to and implementation of the Affordable Care Act, including biologics; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act; FDA Innovation & Safety Act; S.2295, Patient Safety & Generic Labeling Improvement Act; drug shortages; Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protection Recall Act of 2011; Medicaid pharmacy issues.
To suspend temporarily the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thioacetate (Thioester).
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
H.R.5698, legislation temporarily suspending the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thiocetate (Thioester).
Patent Reform Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
Patent Reform Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
Patent Reform Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
Patent Reform Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
Patent Reform Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; and S. 369, Preserve Access to Affordable Generics Act.
Patent Reform Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S. 301, Physicians Payments Sunshine Act of 2009; H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; H.R. 1427 & S. 726, Promoting Innovation & Access to Life-Saving Medicine Act; H.R. 1548, Pathway for Biosimilars Act; legislative proposals relating to the "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA")
Pathway for Biosimilars Act
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
S. 301, Physicians Payments Sunshine Act of 2009; H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; H.R. 1427 & S. 726, Promoting Innovation & Access to Life-Saving Medicine Act; H.R. 1548, Pathway for Biosimilars Act; legislative proposals relating to the "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA")
Protecting Consumer Access to Generic Drugs Act of 2009
Client: TEVA PHARMACEUTICALS USA INC · Firm: TEVA PHARMACEUTICALS USA, INC.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
2017 · third_quarter · Q3
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; HR 749-Lower Drugs Through Competition Act; and FDA Reauthorization Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2017 · second_quarter · Q2
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2017 · first_quarter · Q1
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2016 · fourth_quarter · 4A
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
Patent reform proposals.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2016 · fourth_quarter · Q4
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
Patent reform proposals.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2016 · third_quarter · Q3
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2016 · second_quarter · Q2
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Patent reform proposals.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2016 · first_quarter · Q1
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Patent reform proposals.
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2015 · fourth_quarter · Q4
Patent reform proposals.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2016 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2015 · third_quarter · Q3
Patent reform proposals.
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2015 · second_quarter · Q2
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2015 · first_quarter · Q1
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Drug pricing proposals and issues.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2014 · fourth_quarter · Q4
Trans-Pacific Partnership Trade Agreement; Transatlantic Trade & Investment Partnership Agreement.
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2014 · third_quarter · Q3
Prescription Drug Abuse, STOPP Act HR486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; counterfeit drugs; HR 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H. 3717 Helping Families in Mental Health Crisis Act of 2013; HR4800, FY15 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies;HR 2985, Combinaation Drug Development Incentive Act of 2013; and "21st Century Cures."
Trans-Pacific Partnership Trade Agreement; Transatlantic Trade & Investment Partnership Agreement.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2014 · second_quarter · Q2
Trans-Pacific Partnership Trade Agreement
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2014 · first_quarter · Q1
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Trans-Pacific Partnership Trade Agreement
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act; H.R. 3717 Helping Families in Mental Health Crisis Act of 2013.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2013 · fourth_quarter · Q4
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Trans-Pacific Partnership Trade Agreement
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2013 · third_quarter · Q3
Temporarily suspend the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thiocetate (Thioester).
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Trans-Pacific Partnership Trade Agreement
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2013 · second_quarter · Q2
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Temporarily suspend the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thiocetate (Thioester).
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2013 · first_quarter · 1A
Trans-Pacific Partnership Trade Agreement
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B
Ttemporarily suspend the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thiocetate (Thioester).
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2013 · first_quarter · Q1
Trans-Pacific Partnership Trade Agreement
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives, Plan B
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2012 · fourth_quarter · Q4
Funding for FDA offices; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to and implementation of the Affordable Care Act, including biologics; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act; FDA Innovation & Safety Act; S.2295, Patient Safety & Generic Labeling Improvement Act; drug shortages; Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protection Recall Act of 2011; Medicaid pharmacy issues.
S.27, Preserve Access to Affordable Generics Act; and S.1882, Fair & Immediate Release of Generic Drug Act
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2012 · third_quarter · Q3
Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protection Recall Act of 2011; Medicaid pharmacy issues.
Funding for FDA offices; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform law; implementation of biologics provisions of healthcare reform law; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act; FDA Innovation & Safety Act; and S.2295, Patient Safety & Generic Labeling Improvement Act.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2012 · second_quarter · Q2
Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protection Recall Act of 2011; Medicaid pharmacy issues.
Funding for FDA offices; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform law; implementation of biologics provisions of healthcare reform law; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act; FDA Innovation & Safety Act; and S.2295, Patient Safety & Generic Labeling Improvement Act.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2012 · first_quarter · Q1
S.23, Patent Reform Act of 2011; H.R. 1249, America Invents Act of 2011; and S.27, Preserve Access to Affordable Generics Act
U.S - Israel Trade Agreement; Trans-Pacific Partnership Trade Agreement
Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protection Recall Act of 2011; Medicaid pharmacy issues.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2011 · fourth_quarter · Q4
Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protection Recall Act of 2011; Medicaid pharmacy issues.
Funding for FDA Office of Generic Drugs; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform legislation; implementation of biologics provisions of healthcare reform legislation; H.R.5, Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2011; prescription drug abuse and drug diversion proposals; S. 1357, Affordable Medicines Utilization Act of 2011.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2011 · third_quarter · Q3
Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protrection Recall Act of 2011; Medicaid pharmacy issues.
U.S - Israel Trade Agreement; Trans-Pacific Partnership Trade Agreement
S.23, Patent Reform Act of 2011; H.R. 1249, America Invents Act of 2011; and S.27, Preserve Access to Affordable Generics Act
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2011 · second_quarter · Q2
Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protrection Recall Act of 2011; Medicaid pharmacy issues.
Funding for FDA Office of Generic Drugs; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform legislation; implementation of biologics provisions of healthcare reform legislation; H.R.5, Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2011; prescription drug abuse and drug diversion proposals.
S.23, Patent Reform Act of 2011; H.R. 1249, America Invents Act of 2011; and S.27, Preserve Access to Affordable Generics Act
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2011 · first_quarter · Q1
S.23, Patent Reform Act of 2011; H.R. 1249, America Invents Act of 2011; and S.27, Preserve Access to Affordable Generics Act
U.S - Israel trade agreement
Funding for FDA Office of Generic Drugs; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform legislation; implementation of biologics provisions of healthcare reform legislation; H.R.5, Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2011.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2010 · fourth_quarter · Q4
H.R. 5561/S.3504, Emergency Contraception Education Act (increased Office of Generic Drugs funding) .
H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the "doughnut hole" impact; and implementation of healthcare reform legislation.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2010 · third_quarter · 3A
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals and "paired port" issue.
H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the "doughnut hole" impact; and implementation of healthcare reform legislation.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2010 · third_quarter · 3A
H.R. 5561/S.3504, Emergency Contraception Education Act (increased Office of Generic Drugs funding) .
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals and "paired port" issue.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2010 · third_quarter · Q3
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
H.R. 5561/S.3504, Emergency Contraception Education Act (increased Office of Generic Drugs funding) .
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals and "paired port" issue.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2010 · second_quarter · Q2
H.R. 5561/S.3504, Emergency Contraception Education Act (increased Office of Generic Drugs funding) .
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; S. 369, Preserve Access to Affordable Generics Act; and S. 1315, Drug Price Competition Act of 2009
H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the "doughnut hole" impact; and implementation of healthcare reform legislation.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2010 · first_quarter · Q1
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals and "paired port" issue.
S. 301, Physicians Payments Sunshine Act of 2009; H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; H.R. 1427 & S. 726, Promoting Innovation & Access to Life-Saving Medicine Act; H.R. 1548, Pathway for Biosimilars Act; legislative proposals relating to the "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA")
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; and S. 369, Preserve Access to Affordable Generics Act.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2009 · fourth_quarter · Q4
H.R. 3590, "Patient Protecton and Affordable Care Act of 2009", and H.R. 3962, "Affordable Health Care for America" (provisions relating to pharmaceuticals).
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; and S. 369, Preserve Access to Affordable Generics Act.
S. 301, Physician Payments Sunshine Act of 2009; H.R. 1859 and S. 767, Independent Drug Education and Outreach Act of 2009; H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act; H.R. 1548, Pathway for Biosimilars Act; legislative proposals relating to "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA").
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2009 · third_quarter · Q3
H.R. 3200, "America's Affordable Health Choices Act" and Senate Finance Committee healthcare reform proposal (provisions relating to pharmaceuticals).
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; and S. 369, Preserve Access to Affordable Generics Act.
S. 301, Physician Payments Sunshine Act of 2009; H.R. 1859 and S. 767, Independent Drug Education and Outreach Act of 2009; H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act; H.R. 1548, Pathway for Biosimilars Act; legislative proposals relating to "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA").
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2009 · second_quarter · Q2
Healthcare reform draft legislative proposals, including the Affordable Health Choices Act (Senate draft) - provisions relating to pharmaceuticals.
H.R. 1260, S. 515 and S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; and S. 369, Preserve Access to Affordable Generics Act.
S. 301, Physician Payments Sunshine Act of 2009; H.R. 1859 and S. 767, Independent Drug Education and Outreach Act of 2009; H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act; and H.R. 1548, Pathway for Biosimilars Act; legislation and proposals relating to "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA").
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2009 · first_quarter · Q1
S. 301, Physician Payments Sunshine Act of 2009; H.R. 1859 and S. 767, Independent Drug Education and Outreach Act of 2009; H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act; and H.R. 1548, Pathway for Biosimilars Act; legislation and proposals relating to "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA").
Trade agreements and other trade matters relating to intellectual property and pharmaceuticals.
H.R. 1260, S. 515 & S. 610, Patent Reform Act of 2009; H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009; and S. 369, Preserve Access to Affordable Generics Act.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2008 · fourth_quarter · Q4
Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.
Proposals relating to prescription drug anti-counterfeiting efforts. H.R. 5839 - Safeguarding America's Pharmaceuticals Act of 2008. S. 2029 - Physician Payments Sunshine Act
S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2008 · third_quarter · Q3
Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.
H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007 H.R. 1902 - Protecting Consumer Access to Generic Drugs Act S. 25 - To amend the Federal Food, Drug, and Cosmetic Act to establish requirements for certain petitions submitted to the Food and Drug Administration, and for other purposes. S. 3600 - Patent Reform Act of 2008
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2008 · second_quarter · Q2
Proposals relating to prescription drug anti-counterfeiting efforts. H.R. 5839 - Safeguarding Americas Pharmaceuticals Act of 2008 S. 2029 - Physicians Payments Sunshine Act
President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drugs User Fees. Matters relating to FDA Office of Generic Drugs funding. H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008
S. 623 - Access to Life-Saving Medicines Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 - The Pathway for Biologics Act H.R. 1038 - Access to Life-Saving Medicine Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3610 - Food and Drug Import Safety Act of 2007 S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. H.R. 3624 - Consumer Food Safety Act of 2007
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2008 · first_quarter · 1A
S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 - The Pathway for Biologics Act H.R. 1038 - Access to Life-Saving Medicine Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3610 - Food and Drug Import Safety Act of 2007
H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007 H.R. 1902 - Protecting Consumer Access to Generic Drugs Act
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2008 · first_quarter · Q1
S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 - The Pathway for Biologics Act H.R. 1038 - Access to Life-Saving Medicine Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3610 - Food and Drug Import Safety Act of 2007
H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007 H.R. 1902 - Protecting Consumer Access to Generic Drugs Act
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2007 · year_end · YY
S. 25 - Citizen Petition Fairness and Accuracy Act of 2007 S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act
Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.
H.R. 976 - Children's Health Insurance Program Reauthorization Act of 2007 S. 1893 - Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S. 1951 - The Fair Medicaid Drug Payment Act of 2007
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2007 · mid_year · MM
H.R. 1902 - Protecting Consumer Access to Generic Drugs Act H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007
President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees Matters relating to FDA Office of Generic Drugs funding
Matters relating to Israeli data exclusivity Matters relating to pharmaceutical provisions in free tree agreements.
TEVA PHARMACEUTICALS USA INC via TEVA PHARMACEUTICALS USA, INC.
2006 · year_end · YY
Matters relating to intellectual property provisions in free trade agreements.
Public Law No: 108-173, Medicare Prescription Drug and Modernization Act of 2003; Sec. 641.
H.R. 5384, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007; provisions relating to the Office of Generic Drugs at the Food and Drug Administration. Senate FY 2007 Agriculture Spending Bill; Title IV.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Patent reform proposals.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Trans-Pacific Partnership Trade Agreement
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Ttemporarily suspend the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thiocetate (Thioester).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
H.R.5698, legislation temporarily suspending the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thiocetate (Thioester).
Trans-Pacific Partnership Trade Agreement
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Trans-Pacific Partnership Trade Agreement
S.27, Preserve Access to Affordable Generics Act; and S.1882, Fair & Immediate Release of Generic Drug Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Trans-Pacific Partnership Trade Agreement
S.27, Preserve Access to Affordable Generics Act; and S.1882, Fair & Immediate Release of Generic Drug Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Funding for FDA Office of Generic Drugs; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform law; implementation of biologics provisions of healthcare reform law; H.R.5, Help Efficient Accessible Low-Cost Timely Healthcare (HEALTH) Act of 2011; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
S.23, Patent Reform Act of 2011; H.R. 1249, America Invents Act of 2011; and S.27, Preserve Access to Affordable Generics Act
U.S - Israel Trade Agreement; Trans-Pacific Partnership Trade Agreement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Funding for FDA Office of Generic Drugs; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to healthcare reform legislation; implementation of biologics provisions of healthcare reform legislation; H.R.5, Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2011; prescription drug abuse and drug diversion proposals; S. 1357, Affordable Medicines Utilization Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
U.S - Israel Trade Agreement; Trans-Pacific Partnership Trade Agreement
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protrection Recall Act of 2011; Medicaid pharmacy issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals and "paired port" issue.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
H.R. 5561/S.3504, Emergency Contraception Education Act (increased Office of Generic Drugs funding) .
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the "doughnut hole" impact; and implementation of healthcare reform legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the "doughnut hole" impact; and implementation of healthcare reform legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals and "paired port" issue.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
H.R. 3590, Patient Protection & Affordable Care Act and H.R. 4872, Healthcare & Education Affordability Reconciliation Act (provisions relating to pharmaceuticals).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Trade agreements and other trade-related matters relating to intellectual property and pharmaceuticals.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees. Matters relating to FDA Office of Generic Drugs funding. H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008
S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 - The Pathway for Biologics Act H.R. 1038 - Access to Life-Saving Medicine Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3610 - Food and Drug Import Safety Act of 2007 S.28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. H.R. 3624 - Consumer Food Safety Act of 2007
H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007 H.R. 1902 - Protecting Consumer Access to Generic Drugs Act S. 25 - To amend the Federal Food, Drug, and Cosmetic Act to establish requirements for certain petitions submitted to the Food and Drug Administration, and for other purposes. S. 3600 - Patent Reform Act of 2008
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 623 - Access to Life-Saving Medicines Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 - The Pathway for Biologics Act H.R. 1038 - Access to Life-Saving Medicine Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3610 - Food and Drug Import Safety Act of 2007 S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. H.R. 3624 - Consumer Food Safety Act of 2007
President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drugs User Fees. Matters relating to FDA Office of Generic Drugs funding. H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008
Proposals relating to prescription drug anti-counterfeiting efforts. H.R. 5839 - Safeguarding America's Pharmaceuticals Act of 2008 S. 2029 - Physician Payments Sunshine Act
S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007 H.R. 1902 - Protecting Consumer Access to Generic Drugs Act S. 25 - To amend the Federal Food, Drug, and Cosmetic Act to establish requirements for certain petitions submitted to the Food and Drug Administration, and for other purposes.
Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.
S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.
Proposals relating to prescription drug anti-counterfeiting efforts. H.R. 5839 - Safeguarding Americas Pharmaceuticals Act of 2008.
S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007
President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees. Matters relating to FDA Office of Generic Drugs funding. H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008
S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007
President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees. Matters relating to FDA Office of Generic Drugs funding. H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.
Proposals relating to prescription drug anti-counterfeiting efforts. H.R. 5839 - Safeguarding Americas Pharmaceuticals Act of 2008.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees. Matters relating to FDA Office of Generic Drugs funding.
H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), UNDETERMINED
H.R. 976 - Children's Health Insurance Program Reauthorization Act of 2007 S. 1893 - Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162 - Children's Health and Medicare Protection Act of 2007
H.R. 1038 - Access to Life-Saving Medicine Act S. 1082 - Food and Drug Administration Revitalization Act S. 1088 - Lower PRICED Drugs Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 1956 - The Patient Protection and Innovative Biologic Medicines Act H.R. 2900 - Food and Drug Administration Amendments Act of 2007 H.R. 3140 - Saving Our Community Pharmacy Act of 2007 H.R. 2606 - 340B Program Improvement and Integrity Act of 2007 S. 25 - Citizen Petition Fairness and Accuracy Act of 2007 S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act]
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
H.R. 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges. Patent reform matters. H.R. 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. H.R. 5096, Patents Depend on Quality Act of 2006. S. 3582, Preserve Access to Affordable Generics Act.
S. 3175, Life-Saving Medicines Export Act of 2006. H.R. 6257, Access to Life-Saving Medicine Act. S. 4016, Access to Life-Saving Medicine Act. Matters relating to the Best Pharmaceuticals for Children Act reauthorization and Pediatric Research Equity Act reauthorization. Matters relating to the Prescription Drug User Fee Act reauthorization. S. 3695, A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. H.R. 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. S. 3981, Citizen Petition Fairness and Accuracy Act of 2006. S. 2300, Lower PRICED Drugs Act. H.R. 6022, Lower PRICED Drugs Act. H.R. 5533, Biodefense and Pandemic Vaccine and Drug Development Act of 2006. S. 2564, Biodefense and Pandemic Vaccine and Drug Development Act of 2006, Sec. 5.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)